Antibiotics tested as first treatment for rare eye cancer
NCT ID NCT01820910
Summary
This trial is testing if a long course of the antibiotic doxycycline can control a rare type of eye lymphoma by treating a possible bacterial infection linked to the cancer. It is for adults newly diagnosed with early-stage lymphoma only in the eye area who have not had recent antibiotics. The main goal is to see if this approach keeps the cancer from getting worse for at least two years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MARGINAL ZONE LYMPHOMA OF OCULAR ADNEXAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AO Ospedali Riuniti Papardo Piemonte
Messina, Italy
-
Ematologia
Parma, Italy
-
Molinette 1
Torino, Italy
-
Ospedale Civile
Piacenza, Italy
-
Ospedale San Raffaele
Milan, Italy
-
Ospedale dell'Angelo
Venezia, Italy
-
Università La Sapienza
Rome, Italy
Conditions
Explore the condition pages connected to this study.